Medifast (MED) Management Meetings Reveal Conservatism, not Slowdown - DA Davidson

August 23, 2021 9:30 AM EDT Send to a Friend
DA Davidson analyst Linda Bolton Weiser reiterated a Buy rating and $395.00 price target on Medifast (NYSE: MED) after hosting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login